BOHLIN GAREN G 4
4 · Karyopharm Therapeutics Inc. · Filed Jun 7, 2019
Insider Transaction Report
Form 4
BOHLIN GAREN G
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2019-06-06+25,000→ 25,000 totalExercise: $5.43Exp: 2029-06-05→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option vests as to 100% of the underlying shares on June 6, 2020, provided that the reporting person continues to serve as a director of the issuer through such date.